Oncogenic Ras-induced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells

Journal of Cell Biology

Volumn 152, Issue 6, 2001, Pages 1301-1305

  Fedorov, Yuri V ^a   Scott Rosenthal, R ^a   Olwin, Bradley B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

FGF 2; Mutant; Myoblasts; Proliferation; Ras

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; RAS PROTEIN; SIGNAL PEPTIDE; SODIUM CHLORATE; SURAMIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SKELETAL MUSCLE;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIVISION; CELL LINE; FIBRINOLYTIC AGENTS; FIBROBLAST GROWTH FACTORS; GENES, REPORTER; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; MICE; MUSCLE, SKELETAL; RAS PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SURAMIN; TRANSFECTION;

ANIMALIA;

EID: 0035911967     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.152.6.1301     Document Type: Article

References (40)

1. A serum-free medium that supports the growth of cultured skeletal muscle satellite cells
2. The time course of basic fibroblast growth factor expression in crush-injured skeletal muscles of SJL/J and BALB/c mice
3. Molecular characterization of fibroblast growth factor: Distribution and biological activities in various tissues
4. Increasing complexity of Ras signaling
5. Growth factor control of skeletal muscle differentiation: Commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor
6. Regulation of myogenesis by fibroblast growth factors requires beta-gamma subunits of pertussis toxin-sensitive G proteins
7. Loss of FGF receptor 1 signaling reduces skeletal muscle mass and disrupts myofiber organization in the developing limb
8. Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway
9. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase
10. A role for FGF-6 in skeletal muscle regeneration
11. Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms
12. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion
13. Myogenic growth factor present in skeletal muscle is purified by heparin-affinity chromatography
14. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene
15. A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways
16. The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation
17. A rapid decrease in epidermal growth factor-binding capacity accompanies the terminal differentiation of mouse myoblasts in vitro
18. Myogenic differentiation in permanent clonal myoblast cell lines: Regulation by macromolecular growth factors in the culture medium
19. Solution structure of acidic fibroblast growth factor bound to 1,3,6-naphthalenetrisulfonate: A minimal model for the anti-tumoral action of suramins and suradistas
20. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex
21. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation
22. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate
23. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells
24. Structural basis for FGF receptor dimerization and activation
25. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
26. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis
27. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy
28. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
29. Regulation by heparan sulfate in fibroblast growth factor signaling
30. Recent developments in the cell biology of basic fibroblast growth factor
31. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos
32. Distribution of FGF-2 suggests it has a role in chick limb bud growth
33. Basic fibroblast growth factor in human rhabdomyosarcoma cells: Implications for the proliferation and neovascularization of myoblast-derived tumors
34. Clonal analysis of vertebrate myogenesis. VIII. Fibroblasts growth factor (FGF)-dependent and FGF-independent muscle colony types during chick wing development
35. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction
36. Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation
37. Multiple Ras functions can contribute to mammalian cell transformation
38. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
39. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: Concomitant mutations of the ras genes
40. Cysteine-rich FGF receptor regulates intracellular FGF-1 and FGF-2 levels